abstract |
The present invention relates to general formula (I) Novel substituted pyrimidine compounds of the formula (wherein the chemical groups, substituents, variables and indices are as defined in the specification), and conditions and diseases that can be treated as pharmaceuticals, in particular by inhibition of the PDE4 enzyme Relates to its use as a medicament for treating. |